Literature DB >> 30267388

Neutrophil- and Platelet- to Lymphocyte Ratio in Patients with Euthyroid Hashimoto's Thyroiditis.

Muge Bilge1, Aylia Yesilova1, Mine Adas2, Aysen Helvaci1.   

Abstract

BACKGROUND: Hashimoto's thyroiditis (HT) is the most prevalent autoimmune thyroid disorder. Both neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are reported to be increased in various inflammation-related diseases, but their clinical significance in HT remains unclear.
OBJECTIVES: The aim of this study was to investigate the relationship between thyroid autommunity and NLR and PLR as markers of systemic inflammation in HT.
METHODS: In this study, we evaluated 145 women with HT and 60 age-matched healthy controls. We compared the PLR and the NLR of HT patients with controls and the correlation between the NLR, PLR, and C-reactive protein (CRP), thyroid-stimulating hormone (TSH) and thyroid antibody titers in the patient group. Also we compared the PLR and the NLR of HT patients that received levothyroxine with those who did not receive levothyroxine
RESULTS: There were no significant differences between patient and control groups in terms of overall leukocyte counts, neutrophil counts, and other laboratory tests. In the patient group lymphocyte counts were lower while the platelet counts, NLR (2.29±0.65 vs1.68±0.40), PLR (164.95±55.14 vs106.88±32.19) were higher than those of the control (p<0.001 for all comparisons).
CONCLUSION: In this study we found that NLR and PLR were higher in euthyroid Hashimoto patients than in a healthy control group. NLR and PLR are likely non-specific indicators of immune disorder and their implications for HT and other conditions remain to be elucidated. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2018        PMID: 30267388     DOI: 10.1055/a-0723-3441

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer.

Authors:  Cínthia Minatel Riguetto; Icléia Siqueira Barreto; Frederico Fernandes Ribeiro Maia; Lígia Vera Montali da Assumpção; Denise Engelbrecht Zantut-Wittmann
Journal:  Clinics (Sao Paulo)       Date:  2021-08-16       Impact factor: 2.365

2.  Relationship between Neutrophil-to-Lymphocyte Ratio and Systemic Lupus Erythematosus: A Meta-analysis.

Authors:  Liping Wang; Chunyan Wang; Xuqiang Jia; Minghui Yang; Jing Yu
Journal:  Clinics (Sao Paulo)       Date:  2020-04-17       Impact factor: 2.365

3.  An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.

Authors:  Edgar Carnero Contentti; Guillermo Delgado-García; Juan Criniti; Pablo A López; Juan Pablo Pettinicchi; Edgardo Cristiano; Jimena Miguez; Edgar Patricio Correa-Díaz; Marcelo Oswaldo Álvarez Pucha; Joselyn Elizabeth Miño Zambrano; Enrique Gómez-Figueroa; Verónica Rivas-Alonso; José Flores-Rivera; Verónica Tkachuk; Alejandro Caride; Juan Ignacio Rojas
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

Review 4.  Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies - State of the Art.

Authors:  Michal Mleko; Kazimierz Pitynski; Elzbieta Pluta; Aleksandra Czerw; Katarzyna Sygit; Beata Karakiewicz; Tomasz Banas
Journal:  Cancer Manag Res       Date:  2021-07-09       Impact factor: 3.989

5.  Hemogram parameters in the patients with subacute thyroiditis.

Authors:  Hasret Cengiz; Ceyhun Varim; Taner Demirci; Sedat Cetin
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

6.  Inflammation-Related Markers and Thyroid Function Measures in Pediatric Patients: Is the Grade of Obesity Relevant?

Authors:  Ioana Țaranu; Cecilia Lazea; Victoria Creț; Nicoleta Răcătăianu; Mihaela Iancu; Sorana D Bolboacă
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.